P31-8 Predictors of vulnerability to nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer
DOI:
10.1016/j.annonc.2023.09.372
Publication Date:
2023-11-14T14:40:25Z
AUTHORS (3)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....